Manuel Gotti

3.2k total citations
39 papers, 1.0k citations indexed

About

Manuel Gotti is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Manuel Gotti has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pathology and Forensic Medicine, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Manuel Gotti's work include Lymphoma Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Manuel Gotti is often cited by papers focused on Lymphoma Diagnosis and Treatment (31 papers), Lung Cancer Treatments and Mutations (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Manuel Gotti collaborates with scholars based in Italy, Poland and Ukraine. Manuel Gotti's co-authors include Luca Arcaini, Sara Rattotti, Pier Luigi Zinzani, Marzia Varettoni, Cristiana Pascutto, Francesco Zaja, Marco Paulli, Maurizio Bonfichi, Silvia Zibellini and Mario Cazzola and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Manuel Gotti

35 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manuel Gotti Italy	13	819	389	374	249	188	39	1.0k
Alina S. Gerrie Canada	18	800 1.0×	422 1.1×	465 1.2×	260 1.0×	118 0.6×	110	1.1k
Cathrin Skrabs Austria	18	659 0.8×	343 0.9×	362 1.0×	138 0.6×	172 0.9×	40	1.1k
M. Dreyling Germany	16	1.2k 1.4×	438 1.1×	773 2.1×	261 1.0×	137 0.7×	22	1.3k
Cinzia Pellegrini Italy	20	1.1k 1.4×	294 0.8×	519 1.4×	302 1.2×	317 1.7×	85	1.4k
Niels Murawski Germany	16	716 0.9×	298 0.8×	483 1.3×	340 1.4×	97 0.5×	39	964
Masahiro Yokoyama Japan	15	575 0.7×	325 0.8×	461 1.2×	104 0.4×	185 1.0×	61	1.0k
Igor Aurer Croatia	20	531 0.6×	223 0.6×	449 1.2×	159 0.6×	120 0.6×	88	950
Gregory Bociek United States	14	562 0.7×	230 0.6×	379 1.0×	131 0.5×	131 0.7×	35	836
F. Morschhauser France	13	693 0.8×	182 0.5×	449 1.2×	166 0.7×	168 0.9×	27	944
Alessandro Broccoli Italy	22	1.2k 1.5×	326 0.8×	631 1.7×	375 1.5×	325 1.7×	116	1.6k

Countries citing papers authored by Manuel Gotti

Since Specialization

Citations

This map shows the geographic impact of Manuel Gotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Gotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Gotti more than expected).

Fields of papers citing papers by Manuel Gotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Gotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Gotti. The network helps show where Manuel Gotti may publish in the future.

Co-authorship network of co-authors of Manuel Gotti

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Gotti. A scholar is included among the top collaborators of Manuel Gotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Gotti. Manuel Gotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barcellini, Amelia, Manuel Gotti, Luca Arcaini, et al.. (2024). Future perspectives of radiation therapy for Hodgkin Lymphoma: Risk‐adapted, response‐adapted, and safer than before. Hematological Oncology. 42(3). e3269–e3269. 1 indexed citations

Gardella, Bárbara, Mattia Dominoni, Manuel Gotti, et al.. (2024). Retrospective Investigation of Human Papillomavirus Cervical Infection and Lymphoma Incidence: A Clinical and Pathological Evaluation. Gynecologic and Obstetric Investigation. 89(2). 95–102. 1 indexed citations

McDonald, Andrew, Estelle Verburgh, Manuel Gotti, et al.. (2023). Phase 2 KEYNOTE‐B68 study: pembrolizumab every 6 weeks in relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) or primary mediastinal B‐cell lymphoma (PMBCL). Hematological Oncology. 41(S2). 575–577.

Domingo‐Doménech, Eva, Manuel Gotti, Alessandro Rambaldi, et al.. (2023). THE LOW‐RISK EARLY‐STAGE HODGKIN LYMPHOMA PATIENTS WITH INADEQUATE RESPONSE TO CHEMOTHERAPY. THE PRELIMINARY EXPERIENCE FROM THE RAFTING TRIAL. Hematological Oncology. 41(S2). 674–675.

Colaneri, Marta, Silvia Roda, Alessandra Ricciardi, et al.. (2022). Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy. Journal of Clinical Medicine. 11(24). 7452–7452. 2 indexed citations

Bonometti, Arturo, Luca Diamanti, Matteo Paoletti, et al.. (2021). Hodgkin Lymphoma With Diplopia and Nystagmus: A Paraneoplastic Cerebellar Degeneration With Ectopic Expression of DNER Antigen on Reed-Sternberg Cells. Clinical Lymphoma Myeloma & Leukemia. 22(2). e124–e127. 2 indexed citations

Gotti, Manuel, et al.. (2020). Cancer Immunotherapy Using Chimeric Antigen Receptor Expressing T-Cells: Present and Future Needs of Clinical Cancer Centers. Frontiers in Immunology. 11. 565236–565236. 9 indexed citations

Rigacci, Luigi, Benedetta Puccini, Alessandro Broccoli, et al.. (2019). Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study. Annals of Hematology. 99(2). 283–291. 3 indexed citations

Gac, Anne‐Claire, Loïc Chartier, T. Girinsky, et al.. (2019). OUTCOME AND TREATMENT OF RELAPSING EARLY PET NEGATIVE PATIENTS INCLUDED IN THE EORTC/LYSA/FIL H10 TRIAL ON STAGES I/II HODGKIN LYMPHOMA. Hematological Oncology. 37(S2). 294–296. 4 indexed citations

10.

Ceriani, Luca, Maurizio Martelli, Annarita Conconi, et al.. (2017). Prognostic models for primary mediastinal (thymic) B‐cell lymphoma derived from 18‐FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study. British Journal of Haematology. 178(4). 588–591. 23 indexed citations

11.

Gotti, Manuel, Marta Di Nicola, Marco Lucioni, et al.. (2016). Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma. Hematological Oncology. 35(3). 296–302. 25 indexed citations

12.

Rusconi, Chiara, Maria Luisa Guerrera, Alessandra Tedeschi, et al.. (2015). Outcome of Transformed Marginal Zone Lymphomas Treated in the Rituximab Era. Blood. 126(23). 5098–5098. 3 indexed citations

13.

Rigacci, Luigi, Benedetta Puccini, Pier Luigi Zinzani, et al.. (2015). The prognostic value of positron emission tomography performed after two courses (INTERIM‐PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL). American Journal of Hematology. 90(6). 499–503. 27 indexed citations

14.

Ceriani, Luca, Maurizio Martelli, Pier Luigi Zinzani, et al.. (2015). Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma. Blood. 126(8). 950–956. 134 indexed citations

15.

Arcaini, Luca, Lucia Morello, Alessandra Tucci, et al.. (2014). Autologous stem cell transplantation with in vivo purged progenitor cells shows long‐term efficacy in relapsed/refractory follicular lymphoma. American Journal of Hematology. 90(3). 230–234. 7 indexed citations

16.

Gotti, Manuel, Valeria Fiaccadori, Elisa Bono, et al.. (2013). Therapy-Related Late Adverse Events in Hodgkin’s Lymphoma. INFM-OAR (INFN Catania). 2013. 1–7. 8 indexed citations

17.

Brusamolino, Ercole, Manuel Gotti, & Valeria Fiaccadori. (2012). THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY. Mediterranean Journal of Hematology and Infectious Diseases. 4(1). e2012022–e2012022. 12 indexed citations

18.

Arcaini, Luca, Sara Rattotti, Manuel Gotti, & Stefano Luminari. (2012). Prognostic Assessment in Patients with Indolent B-Cell Lymphomas. The Scientific World JOURNAL. 2012. 1–5. 5 indexed citations

19.

Viviani, Simonetta, Pier Luigi Zinzani, Alessandro Rambaldi, et al.. (2011). ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned. New England Journal of Medicine. 365(3). 203–212. 268 indexed citations

20.

Arcaini, Luca, Marzia Varettoni, Emanuela Boveri, et al.. (2011). Distinctive Clinical and Histological Features of Waldenström's Macroglobulinemia and Splenic Marginal Zone Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 11(1). 103–105. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact